This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Liu, X. Articles by Erikson, R. L. Search for Related Content PubMed PubMed Citation Articles by Liu, X. Articles by Erikson, R. L.

Normal Cells, but Not Cancer Cells, Survive Severe Plk1 Depletion

Xiaoqi Liu,^1,2,* Ming Lei,^1, and Raymond L. Erikson¹

Department of Molecular and Cellular Biology, Harvard University, Cambridge, Massachusetts 02138,¹ Department of Biochemistry and the Cancer Center, Purdue University, West Lafayette, Indiana 47907²

Received 4 September 2005/ Returned for modification 18 October 2005/ Accepted 22 December 2005

We previously reported the phenotype of depletion of polo-like kinase 1 (Plk1) using RNA interference (RNAi) and showed that p53 is stabilized in Plk1-depleted cancer cells. In this study, we further analyzed the Plk1 depletion-induced phenotype in both cancer cells and primary cells. The vector-based RNAi approach was used to evaluate the role of the p53 pathway in Plk1 depletion-induced apoptosis in cancer cells with different p53 backgrounds. Although DNA damage and cell death can occur independently of p53, p53-deficient cancer cells were much more sensitive to Plk1 depletion than cancer cells with functional p53. Next, the lentivirus-based RNAi approach was used to generate a series of Plk1 hypomorphs. In HeLa cells, two weak hypomorphs showed only slight G₂/M arrest, a medium hypomorph arrested with 4N DNA content, followed later by apoptosis, and a strong Plk1 hypomorph underwent serious mitotic catastrophe. In well-synchronized HeLa cells, a medium level of Plk1 depletion caused a 2-h delay of mitotic progression, and a high degree of Plk1 depletion significantly delayed mitotic entry and completely blocked cells at mitosis. In striking contrast, normal hTERT-RPE1 and MCF10A cells were much less sensitive to Plk1 depletion than HeLa cells; no apparent cell proliferation defect or cell cycle arrest was observed after Plk1 depletion in these cells. Therefore, these data further support suggestions that Plk1 may be a feasible cancer therapy target.

X.L. and M.L. contributed equally to this study.

This article has been cited by other articles:

• Shanmugam, M., Hernandez, N. (2008). Mitotic Functions for SNAP45, a Subunit of the Small Nuclear RNA-activating Protein Complex SNAPc. J. Biol. Chem. 283: 14845-14856 [Abstract] [Full Text]  
• Koida, N., Ozaki, T., Yamamoto, H., Ono, S., Koda, T., Ando, K., Okoshi, R., Kamijo, T., Omura, K., Nakagawara, A. (2008). Inhibitory Role of Plk1 in the Regulation of p73-dependent Apoptosis through Physical Interaction and Phosphorylation. J. Biol. Chem. 283: 8555-8563 [Abstract] [Full Text]  
• Xia, F., Lee, C. W., Altieri, D. C. (2008). Tumor Cell Dependence on Ran-GTP-Directed Mitosis. Cancer Res. 68: 1826-1833 [Abstract] [Full Text]  
• Salvatore, G., Nappi, T. C., Salerno, P., Jiang, Y., Garbi, C., Ugolini, C., Miccoli, P., Basolo, F., Castellone, M. D., Cirafici, A. M., Melillo, R. M., Fusco, A., Bittner, M. L., Santoro, M. (2007). A Cell Proliferation and Chromosomal Instability Signature in Anaplastic Thyroid Carcinoma. Cancer Res. 67: 10148-10158 [Abstract] [Full Text]  
• Santamaria, A., Neef, R., Eberspacher, U., Eis, K., Husemann, M., Mumberg, D., Prechtl, S., Schulze, V., Siemeister, G., Wortmann, L., Barr, F. A., Nigg, E. A. (2007). Use of the Novel Plk1 Inhibitor ZK-Thiazolidinone to Elucidate Functions of Plk1 in Early and Late Stages of Mitosis. Mol. Biol. Cell 18: 4024-4036 [Abstract] [Full Text]  
• Morozov, A., Lee, S. J., Zhang, Z.-K., Cimica, V., Zagzag, D., Kalpana, G. V. (2007). INI1 Induces Interferon Signaling and Spindle Checkpoint in Rhabdoid Tumors. Clin. Cancer Res. 13: 4721-4730 [Abstract] [Full Text]  
• Gjoerup, O. V., Wu, J., Chandler-Militello, D., Williams, G. L., Zhao, J., Schaffhausen, B., Jat, P. S., Roberts, T. M. (2007). Surveillance mechanism linking Bub1 loss to the p53 pathway. Proc. Natl. Acad. Sci. USA 104: 8334-8339 [Abstract] [Full Text]  
• Burkard, M. E., Randall, C. L., Larochelle, S., Zhang, C., Shokat, K. M., Fisher, R. P., Jallepalli, P. V. (2007). Chemical genetics reveals the requirement for Polo-like kinase 1 activity in positioning RhoA and triggering cytokinesis in human cells. Proc. Natl. Acad. Sci. USA 104: 4383-4388 [Abstract] [Full Text]  
• Zimmerman, W. C., Erikson, R. L. (2007). Polo-like kinase 3 is required for entry into S phase. Proc. Natl. Acad. Sci. USA 104: 1847-1852 [Abstract] [Full Text]  
• Lansing, T. J., McConnell, R. T., Duckett, D. R., Spehar, G. M., Knick, V. B., Hassler, D. F., Noro, N., Furuta, M., Emmitte, K. A., Gilmer, T. M., Mook, R. A. Jr., Cheung, M. (2007). In vitro biological activity of a novel small-molecule inhibitor of polo-like kinase 1. Molecular Cancer Therapeutics 6: 450-459 [Abstract] [Full Text]  
• Zhang, J., Wang, S., Kern, S., Cui, X., Danner, R. L. (2007). Nitric Oxide Down-regulates Polo-like Kinase 1 through a Proximal Promoter Cell Cycle Gene Homology Region. J. Biol. Chem. 282: 1003-1009 [Abstract] [Full Text]